484 related articles for article (PubMed ID: 9420133)
1. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI).
Maestrelli P; Occari P; Turato G; Papiris SA; Di Stefano A; Mapp CE; Milani GF; Fabbri LM; Saetta M
Clin Exp Allergy; 1997 Nov; 27(11):1292-8. PubMed ID: 9420133
[TBL] [Abstract][Full Text] [Related]
2. Is occupational asthma to diisocyanates a non-IgE-mediated disease?
Jones MG; Floyd A; Nouri-Aria KT; Jacobson MR; Durham SR; Taylor AN; Cullinan P
J Allergy Clin Immunol; 2006 Mar; 117(3):663-9. PubMed ID: 16522468
[TBL] [Abstract][Full Text] [Related]
3. Role of intercellular adhesion molecule-1 in a murine model of toluene diisocyanate-induced asthma.
Furusho S; Myou S; Fujimura M; Kita T; Yasui M; Kasahara K; Nakao S; Takehara K; Sato S
Clin Exp Allergy; 2006 Oct; 36(10):1294-302. PubMed ID: 17014439
[TBL] [Abstract][Full Text] [Related]
4. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma.
Saetta M; Maestrelli P; Di Stefano A; De Marzo N; Milani GF; Pivirotto F; Mapp CE; Fabbri LM
Am Rev Respir Dis; 1992 Jan; 145(1):169-74. PubMed ID: 1309964
[TBL] [Abstract][Full Text] [Related]
5. Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate.
Matheson JM; Johnson VJ; Luster MI
Toxicol Sci; 2005 Mar; 84(1):99-109. PubMed ID: 15590890
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma.
Laberge S; Pinsonneault S; Varga EM; Till SJ; Nouri-Aria K; Jacobson M; Cruikshank WW; Center DM; Hamid Q; Durham SR
J Allergy Clin Immunol; 2000 Aug; 106(2):293-301. PubMed ID: 10932073
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthma.
Choi JH; Nahm DH; Kim SH; Kim YS; Suh CH; Park HS; Ahn SW
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):293-8. PubMed ID: 15478392
[TBL] [Abstract][Full Text] [Related]
8. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate.
Maestrelli P; Del Prete GF; De Carli M; D'Elios MM; Saetta M; Di Stefano A; Mapp CE; Romagnani S; Fabbri LM
Scand J Work Environ Health; 1994 Oct; 20(5):376-81. PubMed ID: 7863302
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and functional outcome in diisocyanate-induced asthma after cessation of exposure.
Piirilä PL; Meuronen A; Majuri ML; Luukkonen R; Mäntylä T; Wolff HJ; Nordman H; Alenius H; Laitinen A
Allergy; 2008 May; 63(5):583-91. PubMed ID: 18394133
[TBL] [Abstract][Full Text] [Related]
10. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.
Hamid Q; Azzawi M; Ying S; Moqbel R; Wardlaw AJ; Corrigan CJ; Bradley B; Durham SR; Collins JV; Jeffery PK
J Clin Invest; 1991 May; 87(5):1541-6. PubMed ID: 2022726
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characterization of the cellular infiltrate in airway mucosa of toluene diisocyanate (TDI)-induced asthma: comparison with allergic asthma.
Park HS; Hwang SC; Nahm DH; Yim HE
J Korean Med Sci; 1998 Feb; 13(1):21-6. PubMed ID: 9539314
[TBL] [Abstract][Full Text] [Related]
12. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate.
Di Stefano A; Saetta M; Maestrelli P; Milani G; Pivirotto F; Mapp CE; Fabbri LM
Am Rev Respir Dis; 1993 Apr; 147(4):1005-9. PubMed ID: 8385428
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of late asthmatic reactions induced by exposure to isocyanates.
Mapp CE; Boschetto P; Zocca E; Milani GF; Pivirotto F; Tegazzin V; Fabbri LM
Bull Eur Physiopathol Respir; 1987; 23(6):583-6. PubMed ID: 2840139
[TBL] [Abstract][Full Text] [Related]
14. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.
Ying S; Humbert M; Barkans J; Corrigan CJ; Pfister R; Menz G; Larché M; Robinson DS; Durham SR; Kay AB
J Immunol; 1997 Apr; 158(7):3539-44. PubMed ID: 9120316
[TBL] [Abstract][Full Text] [Related]
15. Effect of bacterial endotoxin LPS on expression of INF-gamma and IL-5 in T-lymphocytes from asthmatics.
Koch A; Knobloch J; Dammhayn C; Raidl M; Ruppert A; Hag H; Rottlaender D; Müller K; Erdmann E
Clin Immunol; 2007 Nov; 125(2):194-204. PubMed ID: 17884733
[TBL] [Abstract][Full Text] [Related]
16. Late asthmatic reactions, airway inflammation and chronic asthma in TDI sensitized subjects.
Fabbri LM; Picotti G; Mapp CE
Eur Respir J Suppl; 1991 Apr; 13():136s-138s. PubMed ID: 1659425
[TBL] [Abstract][Full Text] [Related]
17. T cells and eosinophils in bronchial smooth muscle cell death in asthma.
Solarewicz-Madejek K; Basinski TM; Crameri R; Akdis M; Akkaya A; Blaser K; Rabe KF; Akdis CA; Jutel M
Clin Exp Allergy; 2009 Jun; 39(6):845-55. PubMed ID: 19400895
[TBL] [Abstract][Full Text] [Related]
18. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.
Johnson VJ; Yucesoy B; Luster MI
J Allergy Clin Immunol; 2005 Oct; 116(4):851-8. PubMed ID: 16210060
[TBL] [Abstract][Full Text] [Related]
19. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.
Molet S; Hamid Q; Davoine F; Nutku E; Taha R; Pagé N; Olivenstein R; Elias J; Chakir J
J Allergy Clin Immunol; 2001 Sep; 108(3):430-8. PubMed ID: 11544464
[TBL] [Abstract][Full Text] [Related]
20. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis.
Saetta M; Di Stefano A; Maestrelli P; Turato G; Mapp CE; Pieno M; Zanguochi G; Del Prete G; Fabbri LM
Clin Exp Allergy; 1996 Jul; 26(7):766-74. PubMed ID: 8842549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
